AOD-9604 Metabolic
Autores: Wilding J
Revista
Curr Opin Investig Drugs
Año
2004
Citas
440
Type
Research Article
Subject
Human
Condition
Obesity / Lipid Metabolism
TL;DR
Metabolic Pharmaceuticals developed AOD-9604 for obesity treatment, with Phase IIa trials underway as of 2002 for this lipolytic peptide fragment of human GH.
Abstract
Metabolic is developing AOD-9604 for the potential treatment of obesity.. By February 2002, phase IIa trials were underway.